In sum, we show here that ER-derived vacuolation via Ca2+ influx, ROS generation, and protein misfolding as well as caspase activation via c-FLIPL downregulation is responsible for the potent anticancer effects of CDDO-Me on breast cancer cells. The gene discussed is CFLAR; the disease is breast cancer.